Showing results (291-300 of 436) with videos related to

Sort By:
Pageof 44
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2010
High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2Yiming Zhou, Lijuan Chen, Bart Barlogie, et al.
The American Journal of Cardiology|April 15, 2004
Bradycardia during therapy for multiple myeloma with thalidomideIbrahim Elias Fahdi, Venkat Gaddam, Jorge F Saucedo, et al.
Toxicology and Applied Pharmacology|October 24, 2007
Time course investigation of PPARalpha- and Kupffer cell-dependent effects of WY-14,643 in mouse liver using microarray gene expressionCourtney G Woods, Oksana Kosyk, Blair U Bradford, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 31, 2013
Patterns of central nervous system involvement in relapsed and refractory multiple myelomaAl-ola Abdallah, Shebli Atrash, Zainab Shahid, et al.
Lancet (London, England)|December 27, 2016
Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trialBrian G M Durie, Antje Hoering, Muneer H Abidi, et al.
Prehospital and Disaster Medicine|September 4, 2019
Rapid Forecasting of Cholera Risk in Mozambique: Translational Challenges and OpportunitiesRebecca Kahn, Ayesha S Mahmud, Andrew Schroeder, et al.
Journal of Sport Rehabilitation|August 17, 2012
Incidence of morphologic changes in asymptomatic Achilles tendons in an active young adult populationMichael F Joseph, Thomas H Trojian, Jeffrey M Anderson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2005
Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humansRebecca E Rudolph, Jason A Dominitz, Johanna W Lampe, et al.
Blood Cancer Journal|August 11, 2019
An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q SyndromeJeffrey R Sawyer, Erming Tian, Brian A Walker, et al.
British Journal of Haematology|May 8, 2013
TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activityMoshe E Gatt, Kohichi Takada, Mala Mani, et al.
Pageof 44